Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

Παρόμοια τεκμήρια

• Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
  ανά: Millar, John S., κ.ά.
  Έκδοση: (2015)
• CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects
  ανά: Thomas, Tiffany, κ.ά.
  Έκδοση: (2017)
• Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
  ανά: Millar, John S., κ.ά.
  Έκδοση: (2017)
• CETP inhibition with Anacetrapib Decreases Fractional Clearance Rates of HDL Apolipoprotein A-I and Plasma CETP
  ανά: Reyes-Soffer, Gissette, κ.ά.
  Έκδοση: (2016)
• Effect of Combination Therapy With Fenofibrate and Simvastatin on Postprandial Lipemia in the ACCORD Lipid Trial
  ανά: Reyes-Soffer, Gissette, κ.ά.
  Έκδοση: (2013)